Free ₹200 worth HealthCash on app
Use HealthCash to order medicines, health products & much more
Get App

Gemfibrozil

Confused about any medicine? Just ask Practo AIFREE

50000+ health queries resolved in last month

Chat with Practo AI on Whatsapp

Not finding what you need? Ask Practo AI

FREE

Chat with Practo AI on Whatsapp

Description

Gemfibrozil is used to reduce the level of bad cholesterol in the body. It is also used to lower the risk of complications of heart disease. Monitoring of cholesterol levels is necessary while receiving this medicine. Maintaining proper diet and adopting lifestyle changes will provide an additive effect.

Side effects

Major & minor side effects for Gemfibrozil

Bladder pain

Fever with chills

Acid or sour stomach

Change in taste

Diarrhea

Heartburn

Dizziness

Headache

Nausea and Vomiting

Skin rash

Uses of Gemfibrozil

What is it prescribed for?

Hypertriglyceridemia

Gemfibrozil is used to lower the elevated triglyceride level.

Hyperlipoproteinemia Type IIb

Gemfibrozil is used to lower the elevated bad cholesterol levels.

Prevention of Cardiovascular Disease

Gemfibrozil is used as a prophylaxis for the prevention of heart diseases in patients with multiple risk factors like smoking, age, and history of heart disease.
Concerns

Commonly asked questions

  • Onset of action

    The peak levels of this medicine can be observed in 1 to 2 hours.
  • Duration of effect

    The effect of this medicine lasts for an average duration of 4 to 6 hours.
  • Safe with alcohol?

    Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.
  • Is it habit forming?

    No habit forming tendency has been reported.
  • Usage in pregnancy?

    This medicine is not recommended for use in pregnant women unless necessary. The risks and benefits should be discussed with the doctor before receiving this medicine.
  • Usage while breast-feeding?

    This medicine is not recommended for use in breastfeeding women.

Allergy

Not recommended in patients with known allergy to Gemfibrozil.

Liver damage

Not recommended in patients with diseases like gall bladder obstruction, primary biliary cirrhosis.

Kidney damage

Not recommended in patients with severe kidney disease.

Warnings for special population

Pregnancy

This medicine is not recommended for use in pregnant women unless necessary. The risks and benefits should be discussed with the doctor before receiving this medicine.

Breast-feeding

This medicine is not recommended for use in breastfeeding women.

General warnings

Muscle injury

Gemfibrozil is known to cause myopathy and elevates creatine phosphokinase levels. Any symptoms of muscle pain, tenderness, and weakness should be reported to the doctor. The treatment should be stopped if the symptoms worsen.

Low blood cell count

Gemfibrozil is known to lower the blood cell count, especially white blood cells and red blood cells. This medicine should be used with caution in patients with existing blood disorders. Close monitoring of blood cell count is necessary during first 12 months of the treatment.

Missed Dose

The missed dose can be taken as soon as you remember. However, if it is time for the next dosage, then the missed dose can be skipped.

Overdose

It is recommended to discontinue the medication and contact your doctor immediately if an overdose is suspected.
All drugs interact differently for person to person. You should check all the possible interactions with your doctor before starting any medicine.

Interaction with Alcohol

Description

Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.

Instructions

Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.

Interaction with Medicine

Simvastatin

Repaglinide

Rosiglitazone

Disease interactions

Liver Disease

Gemfibrozil is not recommended in patients with liver diseases like Primary Biliary Cirrhosis and Gallbladder disease. Inform the doctor if you have any history of liver disease before receiving this medicine. An alternate treatment option should be considered based on the clinical condition.

Food interactions

Information not available.

Lab interactions

Information not available.
Take Gemfibrozil as instructed by the doctor. Do not consume larger quantities than prescribed. Patients with liver disease are not advised to take this medicine. Symptoms of muscle pain, tenderness should be informed to the doctor. It decreases the level of white blood cells and red blood cells. Therefore, monitoring of blood cell count is necessary.

Miscelleneous

To be taken before food

To be taken as instructed by doctor

Does not cause sleepiness

How it works

It works by lowering the levels of bad cholesterol and increasing the levels of good cholesterol.

Legal Status

Approved

Approved

Approved

Approved

Classification

Category

Fibric acid derivatives

Schedule

Schedule H

Gemfibrozil - DrugBank [Internet]. Drugbank.ca. 2017 [cited 15 June 2017]. Available from:

https://www.drugbank.ca/drugs/DB01241

[Internet]. 2017 [cited 15 June 2017]. Available from:

https://www.medicines.org.uk/emc/medicine/16878

DailyMed - Gemfibrozil tablet [Internet]. Dailymed.nlm.nih.gov. 2017 [cited 15 June 2017]. Available from:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=0b50849a-66b6-4e8f-9f45-5425a875d366

Prescribing medicines in pregnancy database [Internet]. Therapeutic Goods Administration (TGA). 2017 [cited 15 June 2017]. Available from:

https://www.tga.gov.au/prescribing-medicines-pregnancy-database

[Internet]. Toxnet.nlm.nih.gov. 2017 [cited 15 June 2017]. Available from:

https://toxnet.nlm.nih.gov/cgi-bin/sis/search2
Something doesn’t feel right?
Report an error

Information on this page was last updated on 5 Jan 2018

Disclaimer

We’ve made all possible efforts to ensure that the information provided here is accurate, up-to-date and complete, however, it should not be treated as a substitute for professional medical advice, diagnosis or treatment. Practo only provides reference source for common information on medicines and does not guarantee its accuracy or exhaustiveness. The absence of a warning for any drug or combination thereof, should not be assumed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Practo does not assume any responsibility for any aspect of healthcare administered with the aid of information provided above. If you have any doubts about your medication then we strongly recommend that you consult with your doctor, nurse or healthcare provider. See detailed T&C here.